These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
308 related articles for article (PubMed ID: 28435450)
1. Exome Sequencing of Oral Squamous Cell Carcinoma Reveals Molecular Subgroups and Novel Therapeutic Opportunities. Su SC; Lin CW; Liu YF; Fan WL; Chen MK; Yu CP; Yang WE; Su CW; Chuang CY; Li WH; Chung WH; Yang SF Theranostics; 2017; 7(5):1088-1099. PubMed ID: 28435450 [TBL] [Abstract][Full Text] [Related]
2. Exome sequencing of oral squamous cell carcinoma in users of Arabian snuff reveals novel candidates for driver genes. Al-Hebshi NN; Li S; Nasher AT; El-Setouhy M; Alsanosi R; Blancato J; Loffredo C Int J Cancer; 2016 Jul; 139(2):363-72. PubMed ID: 26934577 [TBL] [Abstract][Full Text] [Related]
3. Precise Identification of Recurrent Somatic Mutations in Oral Cancer Through Whole-Exome Sequencing Using Multiple Mutation Calling Pipelines. Lin LH; Chou CH; Cheng HW; Chang KW; Liu CJ Front Oncol; 2021; 11():741626. PubMed ID: 34912705 [TBL] [Abstract][Full Text] [Related]
4. Genetically-defined novel oral squamous cell carcinoma cell lines for the development of molecular therapies. Fadlullah MZ; Chiang IK; Dionne KR; Yee PS; Gan CP; Sam KK; Tiong KH; Ng AK; Martin D; Lim KP; Kallarakkal TG; Mustafa WM; Lau SH; Abraham MT; Zain RB; Rahman ZA; Molinolo A; Patel V; Gutkind JS; Tan AC; Cheong SC Oncotarget; 2016 May; 7(19):27802-18. PubMed ID: 27050151 [TBL] [Abstract][Full Text] [Related]
5. Identification of Somatic Mutations in Plasma Cell-Free DNA from Patients with Metastatic Oral Squamous Cell Carcinoma. Lin LH; Chang KW; Cheng HW; Liu CJ Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373553 [TBL] [Abstract][Full Text] [Related]
6. Translational genomics and recent advances in oral squamous cell carcinoma. Chai AWY; Lim KP; Cheong SC Semin Cancer Biol; 2020 Apr; 61():71-83. PubMed ID: 31542510 [TBL] [Abstract][Full Text] [Related]
8. A novel genomic signature reclassifies an oral cancer subtype. Samman M; Wood HM; Conway C; Stead L; Daly C; Chalkley R; Berri S; Senguven B; Ross L; Egan P; Chengot P; Ong TK; Pentenero M; Gandolfo S; Cassenti A; Cassoni P; Al Ajlan A; Samkari A; Barrett W; MacLennan K; High A; Rabbitts P Int J Cancer; 2015 Nov; 137(10):2364-73. PubMed ID: 26014678 [TBL] [Abstract][Full Text] [Related]
9. Whole-Exome Sequencing Analysis of Oral Squamous Cell Carcinoma Delineated by Tobacco Usage Habits. Patel K; Bhat FA; Patil S; Routray S; Mohanty N; Nair B; Sidransky D; Ganesh MS; Ray JG; Gowda H; Chatterjee A Front Oncol; 2021; 11():660696. PubMed ID: 34136393 [TBL] [Abstract][Full Text] [Related]
10. Comparing Genomic Landscapes of Oral and Cutaneous Squamous Cell Carcinoma of the Head and Neck: Quest for Novel Diagnostic Markers. Gupta R; Strbenac D; Satgunaseelan L; Cheung VK; Narayanappa H; Ashford B; Mitchell J; Thind A; Palme CE; Ch'ng S; Low TH; Wykes J; Willet CE; Chew T; Yang J; Ranson M; Clark JR Mod Pathol; 2023 Aug; 36(8):100190. PubMed ID: 37080394 [TBL] [Abstract][Full Text] [Related]
11. Noninvasive genomic profiling of somatic mutations in oral cavity cancers. Xi Y; Negrao MV; Akagi K; Xiao W; Jiang B; Warner SC; Dunn JD; Wang J; Symer DE; Gillison ML Oral Oncol; 2023 May; 140():106372. PubMed ID: 37004423 [TBL] [Abstract][Full Text] [Related]
12. Mutational landscape of gingivo-buccal oral squamous cell carcinoma reveals new recurrently-mutated genes and molecular subgroups. India Project Team of the International Cancer Genome Consortium Nat Commun; 2013; 4():2873. PubMed ID: 24292195 [TBL] [Abstract][Full Text] [Related]
13. Multi-regional genomic and transcriptomic characterization of a melanoma-associated oral cavity cancer provide evidence for CASP8 alteration-mediated field cancerization. Chakravarty S; Ghosh A; Das C; Das S; Patra S; Maitra A; Ghose S; Biswas NK Hum Genomics; 2024 Sep; 18(1):96. PubMed ID: 39244622 [TBL] [Abstract][Full Text] [Related]
14. Mutational spectrum of tobacco associated oral squamous carcinoma and its therapeutic significance. Batta N; Pandey M World J Surg Oncol; 2019 Nov; 17(1):198. PubMed ID: 31775759 [TBL] [Abstract][Full Text] [Related]
15. NOTCH1 mutations as prognostic marker in oral squamous cell carcinoma. Wu-Chou YH; Hsieh CH; Liao CT; Lin YT; Fan WL; Yang CH Pathol Res Pract; 2021 Jul; 223():153474. PubMed ID: 33993060 [TBL] [Abstract][Full Text] [Related]
16. Targeting the DNA Damage Response in OSCC with TP53 Mutations. Lindemann A; Takahashi H; Patel AA; Osman AA; Myers JN J Dent Res; 2018 Jun; 97(6):635-644. PubMed ID: 29489434 [TBL] [Abstract][Full Text] [Related]
17. Combined mutational analysis of RAS, BRAF, PIK3CA, and TP53 genes in Taiwanese patients with oral squamous cell carcinoma. Chang YS; Hsu HT; Ko YC; Yeh KT; Chang SJ; Lin CY; Chang JG Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Jul; 118(1):110-116.e1. PubMed ID: 24908601 [TBL] [Abstract][Full Text] [Related]
18. The mutational spectrum of squamous-cell carcinoma of the head and neck: targetable genetic events and clinical impact. Mountzios G; Rampias T; Psyrri A Ann Oncol; 2014 Oct; 25(10):1889-1900. PubMed ID: 24718888 [TBL] [Abstract][Full Text] [Related]
19. Relevance and actionable mutational spectrum in oral squamous cell carcinoma. Jayaprakash C; Varghese VK; Jayaram P; Chakrabarty S; Kudva A; Ray S; Satyamoorthy K J Oral Pathol Med; 2020 May; 49(5):427-434. PubMed ID: 31845386 [TBL] [Abstract][Full Text] [Related]